$HCA

HCA Holdings, Inc.

CIK:0000860730|SEC Filings

Condensed Consolidated Income Statements (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 20,230	$ 18,605	$ 39,339	$ 36,926
Salaries and benefits	8,290	8,138	16,573	16,135
Supplies	2,886	2,844	5,739	5,608
Other operating expenses	5,043	3,793	9,223	7,638
Equity in earnings of affiliates	(16)	(19)	(25)	(37)
Depreciation and amortization	944	863	1,874	1,723
Interest expense	599	568	1,183	1,115
Losses (gains) on sales of facilities	(10)	3	(9)	2
Total expenses including equity in earnings of affiliates	17,736	16,190	34,558	32,184
Income before income taxes	2,494	2,415	4,781	4,742
Provision for income taxes	564	524	994	1,026
Net income	1,930	1,891	3,787	3,716
Net income attributable to noncontrolling interests	231	238	468	453
Net income attributable to HCA Healthcare, Inc.	$ 1,699	$ 1,653	$ 3,319	$ 3,263
Per share data:
Basic earnings	$ 7.7	$ 6.91	$ 14.95	$ 13.43
Diluted earnings	$ 7.62	$ 6.83	$ 14.77	$ 13.28
Shares used in earnings per share calculations (in millions):
Basic	220,538	239,173	222,055	243,033
Diluted	222,828	241,911	224,731	245,654

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income	$ 3,787	$ 3,716
Increase (decrease) in cash from operating assets and liabilities:
Accounts receivable	(1,417)	320
Inventories and other assets	(26)	(427)
Accounts payable and accrued expenses	(439)	(676)
Depreciation and amortization	1,874	1,723
Income taxes	269	880
Losses (gains) on sales of facilities	(9)	2
Amortization of debt issuance costs and discounts	23	25
Share-based compensation	171	197
Other	116	101
Net cash provided by operating activities	4,349	5,861
Cash flows from investing activities:
Purchase of property and equipment	(2,350)	(2,167)
Acquisition of hospitals and health care entities	(386)	(326)
Sales of hospitals and health care entities	21	167
Change in investments	(120)	41
Other	(4)	2
Net cash used in investing activities	(2,839)	(2,283)
Cash flows from financing activities:
Issuance of long-term debt	2,994	5,233
Net change in short-term borrowings and revolving credit facility	2,679	1,768
Repayment of long-term debt	(2,608)	(5,660)
Distributions to noncontrolling interests	(334)	(394)
Payment of debt issuance costs	(17)	(57)
Payment of dividends	(354)	(351)
Repurchase of common stock	(3,635)	(5,011)
Other	(259)	(112)
Net cash used in financing activities	(1,534)	(4,584)
Effect of exchange rate changes on cash and cash equivalents	(3)	12
Change in cash and cash equivalents	(27)	(994)
Cash and cash equivalents at beginning of period	1,040	1,933
Cash and cash equivalents at end of period	1,013	939
Interest payments	1,163	1,074
Income tax payments, net	$ 725	$ 146

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 1,013	$ 1,040
Accounts receivable	12,281	10,867
Inventories	1,662	1,652
Other	2,234	2,224
Total current assets	17,190	15,783
Property and equipment, at cost	68,409	66,275
Accumulated depreciation	(36,593)	(35,134)
Property and equipment, net	31,816	31,141
Investments of insurance subsidiaries	402	485
Investments in and advances to affiliates	813	633
Goodwill and other intangible assets	10,662	10,293
Right-of-use operating lease assets	2,109	2,130
Other	258	255
Total assets	63,250	60,720
Current liabilities:
Accounts payable	4,752	4,659
Accrued salaries	2,199	2,525
Other accrued expenses	4,097	4,277
Short-term borrowings and long-term debt due within one year	6,264	4,889
Total current liabilities	17,312	16,350
Long-term debt, less debt issuance costs and discounts of $451and $436	43,454	41,603
Professional liability risks	1,464	1,466
Right-of-use operating lease obligations	1,834	1,853
Income taxes and other liabilities	2,395	2,219
Stockholders' (deficit) equity:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 217,963,300 shares - 2026 and 224,605,100 shares - 2025	2	2
Accumulated other comprehensive loss	(334)	(305)
Retained deficit	(6,310)	(5,724)
Stockholders' deficit attributable to HCA Healthcare, Inc.	(6,642)	(6,027)
Noncontrolling interests	3,433	3,256
Total stockholders' (deficit) equity	(3,209)	(2,771)
Total liabilities and stockholders' (deficit) equity	$ 63,250	$ 60,720